Personalized Medicine in Post-COVID-19 Era

Dear Colleagues,

Concerning the post-COVID patients, personalized medicine is of significant medical interest. The identification of biomarkers that could guide the personalized approach of these patients could allow for the identification of the most effective diagnosis and treatment methods.

The Special Issue entitled "Personalized Medicine in Post-COVID-19 Era" of the Journal of Personalized Medicine will highlight the importance of understanding the main factors that influence individual responses to the virus and lead to more targeted and effective treatment strategies. In addition, it will focus on why certain individuals are more prone to long COVID and how to manage their symptoms more effectively. We hope that research tools such as proteomics, genomics, metabolomics and epigenomics will allow for the identification of guidelines for a personalized approach, and could help identify the patients who may need alternative vaccination strategies. Personalized medicine can help in identifying existing drugs that may be more effective for certain subgroups of COVID-19 patients, leading to potential drug repurposing for better outcomes. It is important to note that the field of personalized medicine is continuously evolving, and new research and developments are likely to emerge as more data are collected and analyzed.

Prof. Dr. Cristian Oancea
Dr. Elena Cojocaru
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.